263 related articles for article (PubMed ID: 31029505)
21. C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis.
Ye B; Chen B; Guo C; Xiong N; Huang Y; Li M; Lai Y; Li J; Zhou M; Wang S; Wang S; Yang N; Zhang H
Mol Ther; 2024 May; 32(5):1540-1560. PubMed ID: 38449312
[TBL] [Abstract][Full Text] [Related]
22. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
[TBL] [Abstract][Full Text] [Related]
23. Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b
Antoniou K; Ender F; Vollbrandt T; Laumonnier Y; Rathmann F; Pasare C; Singh H; Köhl J
Cells; 2020 Jan; 9(2):. PubMed ID: 31991941
[TBL] [Abstract][Full Text] [Related]
24. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
25. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.
Lok SWY; Yiu WH; Li H; Xue R; Zou Y; Li B; Chan KW; Chan LYY; Leung JCK; Lai KN; Tang SCW
Clin Sci (Lond); 2020 Nov; 134(21):2873-2891. PubMed ID: 33078834
[TBL] [Abstract][Full Text] [Related]
26. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
[TBL] [Abstract][Full Text] [Related]
27. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function.
Li XX; Lee JD; Massey NL; Guan C; Robertson AAB; Clark RJ; Woodruff TM
Biochem Pharmacol; 2020 Oct; 180():114156. PubMed ID: 32682759
[TBL] [Abstract][Full Text] [Related]
29. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
Front Immunol; 2019; 10():1866. PubMed ID: 31447855
[TBL] [Abstract][Full Text] [Related]
30. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
Front Immunol; 2021; 12():652242. PubMed ID: 33936074
[TBL] [Abstract][Full Text] [Related]
31. Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.
Merle NS; Leon J; Poillerat V; Grunenwald A; Boudhabhay I; Knockaert S; Robe-Rybkine T; Torset C; Pickering MC; Chauvet S; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2020; 11():1772. PubMed ID: 32849636
[TBL] [Abstract][Full Text] [Related]
32. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
[TBL] [Abstract][Full Text] [Related]
33. Collectin-11 Promotes the Development of Renal Tubulointerstitial Fibrosis.
Wu W; Liu C; Farrar CA; Ma L; Dong X; Sacks SH; Li K; Zhou W
J Am Soc Nephrol; 2018 Jan; 29(1):168-181. PubMed ID: 29142050
[TBL] [Abstract][Full Text] [Related]
34. Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.
Shi YW; Zhang XC; Chen C; Tang M; Wang ZW; Liang XM; Ding F; Wang CP
Brain Behav Immun; 2017 Nov; 66():244-256. PubMed ID: 28690033
[TBL] [Abstract][Full Text] [Related]
35. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin.
Sadik CD; Miyabe Y; Sezin T; Luster AD
Semin Immunol; 2018 Jun; 37():21-29. PubMed ID: 29602515
[TBL] [Abstract][Full Text] [Related]
36. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models.
Benson MJ; Thomas NK; Talwar S; Hodson MP; Lynch JW; Woodruff TM; Borges K
Neurobiol Dis; 2015 Apr; 76():87-97. PubMed ID: 25681535
[TBL] [Abstract][Full Text] [Related]
37. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
Woodruff TM; Shukla AK
Trends Immunol; 2020 Nov; 41(11):965-967. PubMed ID: 33023856
[TBL] [Abstract][Full Text] [Related]
38. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
39. Respiratory Syncytial Virus Exacerbates Kidney Damages in IgA Nephropathy Mice via the C5a-C5aR1 Axis Orchestrating Th17 Cell Responses.
Hu X; Feng J; Zhou Q; Luo L; Meng T; Zhong Y; Tang W; Deng S; Li X
Front Cell Infect Microbiol; 2019; 9():151. PubMed ID: 31134161
[TBL] [Abstract][Full Text] [Related]
40. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
